RecruitingNCT06126224

Safety and Efficacy of KarXT for Psychosis Associated With Alzheimer's Disease

Official study title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

Medication studyAges 55–90Multiple countriesSchizophrenia

The study in practice

Understand this study

Who could participate?

Listed age limits: 55 years to 90 years.

Listed locations: Chandler, United States · Phoenix, United States and 114 more locationsSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 28, 2023

Recruitment status: Recruiting
Enrollment listed in the registry: 500
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sponsor type: Biotech company
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: United States, Canada, United Kingdom, ...
Age range: From 55 Years to 90 Years
Official registry ID: NCT06126224

Want help reviewing this study?

Study ID: NCT06126224. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Chandler, United States · Phoenix, United States · Anaheim, United States

113 more locations

Canoga Park, United States
Encino, United States
Lancaster, United States
Los Alamitos, United States
Sherman Oaks, United States
Walnut Creek, United States
Apopka, United States
Clermont, United States
Cutler Bay, United States
Delray Beach, United States
Doral, United States
Fort Myers, United States
Hialeah, United States
Homestead, United States
Largo, United States
Maitland, United States
Miami, United States
Miami Gardens, United States
Miami Lakes, United States
Orlando, United States
Port Orange, United States
Stuart, United States
Sweetwater, United States
Tampa, United States
The Villages, United States
Viera, United States
Augusta, United States
Columbus, United States
Decatur, United States
Elgin, United States
Marrero, United States
Rochester Hills, United States
Flowood, United States
Las Vegas, United States
New Hyde Park, United States
Port Jefferson Station, United States
Dayton, United States
Malvern, United States
Cypress, United States
Houston, United States
Katy, United States
Red Oak, United States
Stafford, United States
Hasselt, Belgium
Leuven, Belgium
Roeselare, Belgium
Calgary, Canada
Hamilton, Canada
Toronto, Canada
Whitby, Canada
Montreal, Canada
Verdun, Canada
Las Condes, Chile
Providencia, Chile
Antofagasta, Chile
Hefei, China
Beijing, China
Chongqing, China
Guangzhou, China
Shenzhen, China
Nanjing, China
Nanchang, China
Shanghai, China
Chengdu, China
Zigong, China
Tianjin, China
Hangzhou, China
Wenzhou, China
Athens, Greece
Chaidari, Athens, Greece
Marousi, Greece
Heraklion, Greece
Pécs, Hungary
Budapest, Hungary
Miskolc, Hungary
Saltillo Centro, Mexico
Zona Urbana Río Tijuana, Mexico
Zapopan, Mexico
Monterrey, Mexico
Culiacán, Mexico
México, Mexico
Miraflores, Peru
Pueblo Libre, Peru
Callao, Peru
Lublin, Poland
Lodz, Poland
Sopot, Poland
Katowice, Poland
Bydgoszcz, Poland
Siemianowice Śląskie, Poland
Ścinawa, Poland
Buk-gu, South Korea
Seongnam-si, South Korea
Incheon, South Korea
Seoul, South Korea
Busan, South Korea
Geneva, Switzerland
Lausanne, Switzerland
Atakum, Türkiye
Eskişehir, Türkiye
Istanbul, Türkiye
Izmir, Türkiye
Ilford, United Kingdom
Swinton, United Kingdom
London, United Kingdom
Aberdeen, United Kingdom
Chertsey, United Kingdom
Edinburgh, United Kingdom
Leeds, United Kingdom
Motherwell, United Kingdom
Preston, United Kingdom
Sheffield, SouthYorkshire, United Kingdom
Türkiye

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Karuna Therapeutics, Inc., a Bristol Myers Squibb company.

Does this study involve medication?

Yes. The study involves medication, including KarXT and Placebo.

Who can participate?

Listed age limits: 55 years to 90 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me